Jacobi Capital Management LLC Cassava Sciences Inc Transaction History

Jacobi Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$36.77 - $90.91 $73,540 - $181,820	-2,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$41.79 - $135.3 $83,580 - $270,600	2,000 New	2,000 $124,000
Q1 2020 Apr 24, 2020	SELL	$3.26 - $9.65 $0 - $0	0 Closed	0 $0
Q4 2019 Feb 03, 2020	BUY	$1.1 - $6.12 $0 - $0	0 New	0 $0

207

14M

2.98M

6.57M

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $154M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

Get notified when there are updates to the investment portfolio of Jacobi Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Jacobi Capital Management LLC with notifications on news.